Since WNT/Beta-catenin pathway, TGF-beta signaling, c-MYC signaling, and G2/M checkpoint are involved in various aspects of cancer development [54,55,56,57], downregulation of all these pathways upon exposure to SSRE can be used to predict anti-cancer properties of the extract. The gene discussed is MYC; the disease is cancer.